Wednesday, June 10, 2026

pharma Β· Hemophilia A Β· Hemophilia A or B With Inhibitors

Baxalta Innovations

Baxalta Innovations clinical programs β€” 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Illinois, USA HQ
2015 Founded
475 Employees
EMA registrant Type
Company details
Status
Public
HQ
Illinois, USA
Founded
2015
Employees
475
Programs
6
Drugs
12
Patents
1
Intelligence Β· Clinical Programs

Baxalta Innovations projects

0 ClinicalTrials.gov programs sponsored by Baxalta Innovations.

Baxalta Innovations has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

No programs matched

Try a different phase filter or check back as we index more trials.

Frequently asked questions

How many clinical projects does Baxalta Innovations have?

0 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.